Acrivon Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Acrivon Therapeutics, Inc.
CIK #0001781174
EDGAR Form CIK 2011 - 2025
10-K [0001781174]
10-Q [0001781174]
3 [0001781174]
4 [0001781174]
8-K [0001781174]
D [0001781174]
SC 13D [0001781174]
SC 13G [0001781174]
Form 13D/13G Filer Form 13D/13G Subject Filed
Marshall Wace North America LP Acrivon Therapeutics Inc [2023-02-14]
Chione Ltd Acrivon Therapeutics Inc [2022-11-28]
RA Capital Management LP Acrivon Therapeutics Inc [2022-11-28]
Sands Capital Life Sciences Pulse Fund II LP Acrivon Therapeutics Inc [2022-11-25]
Citadel Advisors LLC Acrivon Therapeutics Inc [2022-11-21]
Perceptive Advisors LLC Acrivon Therapeutics Inc [2022-11-18]
Form 3/4/5 Subject 2011 - 2025
Gamelin Erick
Acrivon Therapeutics, Inc.
Masson Kristina
Blume-Jensen Peter
Devroe Eric
Peterson Katharine
Miller Mary
Levy Adam D.
Palani Santhosh
RA Capital Management LP
View All
Terms | Privacy | Guide
tony@aum13f.com